Skip to content

Evaluation of Pétale® (Small Hearing Test Equipment for Children) for the Screening of Hearing Disorders in Children From 9 Months to 3 Years Old by the General Practitioner or Pediatrician

Evaluation of Pétale® (Small Hearing Test Equipment for Children) for the Screening of Hearing Disorders in Children From 9 Months to 3 Years Old by the General Practitioner or Pediatrician

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05117801
Acronym
PETALE
Enrollment
300
Registered
2021-11-11
Start date
2021-01-04
Completion date
2022-07-04
Last updated
2021-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child Development, Hearing Disorders, Petale

Brief summary

The aim of this study is to confirm the value of this new version of Pétale® ((small equipment for testing the child's hearing) in the daily practice of general practitioners or pediatricians for the screening of hearing disorders in very young children.

Detailed description

The research procedure is auditory stimulation using Pétale® (small equipment for testing the child's hearing) based on the orientation reflex (Ewing test): the child is seated on the companion's knees between the two enclosures and the investigator observes whether or not he is attracted to a familiar calibrated noise coming from one side or the other.

Interventions

DEVICEPetale

The child sits on the companion's lap between the two enclosures, and the investigator observes whether or not he is attracted to a familiar calibrated noise coming from one side or the other.

Sponsors

European Clinical Trial Experts Network
CollaboratorOTHER
Ramsay Générale de Santé
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
9 Months to 3 Years
Healthy volunteers
Yes

Inclusion criteria

* Chil, girl or boy between 9 months and 3 years-old * Child seen in consultation by a general practitioner or a pediatrician whatever the reason for consultation * Child attached to a beneficiary of a social security scheme * Signature of informed consent by parents.

Exclusion criteria

* Age greater than 3 years and less than 9 months * Refusal of one or more parents during the consultation * State of the child which does not allow the screening test to be carried out

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity2 weeksProportion of children with a hearing impairment assessed by the investigator knowing that they were also assessed with a hearing impairment by ENT specialist.
Specificity2 weeksProportion of children without hearing impairment assessed by the investigator knowing that they were also assessed without hearing impairment by ENT.
Positive Predictive Value (PPV):2 weeksProportion of children with hearing impairment assessed by both investigator and ENT among children with hearing impairment assessed by ENT.
Negative Predictive Value (NPV)2 weeksProportion of children without hearing impairment assessed by both investigator and ENT among children without hearing impairment assessed by ENT.

Countries

France

Contacts

Primary ContactJean-François Oudet
jf.oudet@ecten.eu0683346567
Backup ContactMarie-Hélène Barba
mh.barba@ecten.eu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026